baber/WOPTO huggingface dataset:
Patent DE-69520007-T2 (DE)
Inventor: GUPTA KUMAR
IPC: C22F1/04
Filed: 1995-09-05
Granted: 2001-05-23
Abstract: A process of producing solution heat treated aluminum alloy sheet material comprises subjecting hot- or cold-rolled aluminum alloy sheet to solution heat treatment followed by quenching and, before substantial age hardening has taken place, subjecting the alloy sheet material to one or more subsequent heat treatments involving heating the material to a peak temperature in the range of 100 DEG  to 300 DEG  C. (preferably 130 DEG -270 DEG  C.), holding the material at the peak temperature for a period of time less than about 1 minute, and cooling the alloy from the peak temperature to a temperature of 85 DEG  C. or less. The sheet material treated in this way can be used for automotive panels and has good a good "paint bake response", i.e. an increase in yield strength from the T4 temper to the T8X temper upon painting and baking of the panels.
Patent DE-69529300-T2 (DE)
Inventor: DUPONT ERIC
IPC: A61K38/02
Filed: 1995-10-30
Granted: 2003-07-03
Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, direct anti-tumor proliferating, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being centrifuged and further fractionated to obtain a total extract having molecules of a molecular weight comprised between 0 to 500 KDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components. Due to the multiplicity of biological activities of the total liquid extract, it can be used for treating numerous diseases or conditions such as those having components selected from the group consisting of tumor proliferation, angiogenesis, inflammation and collagenolysis. This extract has no offensive effect on normal body functions. Therefore, this shark cartilage extract has a very promising therapeutic value. The process for the obtention of cartilage extracts is simple and efficient. The unexpectedly valuable products obtained by this process are therefore an indication of a new and non-obvious process.
Patent DE-69535452-T2 (DE)
Inventor: DEJACO ANDREW P
IPC: G10L19/24
Filed: 1995-08-01
Granted: 2007-12-13
Abstract: A method of adding hangover frames to a plurality of frames encoded by a vocoder, the method comprising: detecting that a predefined number of successive frames has been encoded at a first rate; determining that a next successive frame should be encoded at a second rate that is less than the first rate; and selecting a number of successive hangover frames beginning with the next successive frame to encode at the first rate, the numbering dependent upon an estimate of a background noise level.
Patent DE-69607631-T2 (DE)
Inventor: WILF ITZHAK
IPC: H04N5/272
Filed: 1996-09-09
Granted: 2000-07-27
Abstract: Apparatus for automatic electronic replacement of a billboard in a video image including an automatic camera orientation measurement apparatus including motion measurement means operative to measure the Field of View (FOV) of the TV camera relative to a known reference position. <IMAGE>
Patent DE-69620233-T2 (DE)
Inventor: BALAZOVSKY MARK BORISOVICH
IPC: A61K38/00
Filed: 1996-12-10
Granted: 2002-11-14
Abstract: The invention relates to medicine, in particular to pharmacology and therapy. According to the invention method of stimulating endogenous production of cytokine and hemopoietic factors comprising introducing to a mammalian body in need of stimulation of cytokine or hemopoietic factor or both, an effective amount of oxidized glutathione, its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative, for a period of time to stimulate said endogenous production to obtain a therapeutic effect, wherein said oxidized glutathione, or/and its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative is introduced parenterally or topically. According to the invention, oxidized glutathione or/and its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative is introduced along with an extender of the half life of said oxidized glutathione or/and its pharmaceutically acceptable salt form, or/and its pharmaceutically acceptable derivative.
Patent DE-69630783-T2 (DE)
Inventor: SCHELL DAVID LOUIS
IPC: G11B7/125
Filed: 1996-01-18
Granted: 2004-08-19
Abstract: The optical drive system described comprises an optical assembly, a light source, an objective lens disposed in an objective lens subassembly, an actuator assembly which suspends the objective lens subassembly for relative motion thereof with respect to the actuator assembly, first and second servomotors for moving the objective lens subassembly in tracking and focusing directions, respectively, relative to the actuator assembly, a third servomotor for moving the actuator assembly in the tracking direction relative to a medium, first electronic means for controlling the first, second, and third servomotors, a motor with a hub assembly for moving the medium relative to the objective lens subassembly, a photo detector, second electronic means responsive to an output signal of the photo detector for decoding information carried in the light returning from the medium, third electronic means for enabling the light source to emit light at a first intensity level to encode information on the medium and at a second intensity level to read information encoded thereon, data receiving means for accepting data that is storable on the medium, data encoding means being responsive to the data receiving means for representing the data to be stored in a predetemined format, the data encoding means also for directing data to the third electronic means, a magnetic field generator for producing a magnetic field on a portion of the medium and for coacting with the third electronic means and the light source to write and erase information on the medium, a cartridge loading assembly, servo error detecting means coupled to the first electronic means, and a housing structure for positioning components of the optical drive system with respect to one another.The system claimed include means to monitor and use a Quad Sum signal associated with the return light for focus capture.
Patent DE-69634080-T2 (DE)
Inventor: EDSMAN KATARINA
IPC: A61K9/00
Filed: 1996-05-03
Granted: 2006-03-02
Abstract: Method for preventing posterior capsule opacification comprising administration of a controlled release composition containing a cytotoxic agent wherein the composition releases more than 30 % of the total amount of the drug during day 1-7 after surgery and contains less than 10 % of the drug at day 14 after surgery.
Patent DE-69713498-T2 (DE)
Inventor: HSICH GARY
IPC: G01N27/447
Filed: 1997-03-31
Granted: 2003-02-20
Abstract: This invention provides an improved assays for the detection of transmissable spongiform encephalopathies (TSEs) in humans and non-human mammals. The methods involve detecting the presence or absence of 14-3-3 proteins in cerebrospinal fluid from the tested organism. Elevated levels of 14-3-3 are indicative of transmissable spongiform encephalopathies, in particular Cretzfeldt-Jacob disease in humans or mad cow disease in bovines).
Patent DE-69717101-T2 (DE)
Inventor: BOURES EMMANUEL
IPC: C12P19/44
Filed: 1997-05-23
Granted: 2003-09-25
Abstract: The present invention embraces methods and compositions which employ antimicrobial compositions which are alpha-alkylglucosides and esters thereof.
Patent DE-69731892-T2 (DE)
Inventor: SCHWARTZ S
IPC: A61M39/06
Filed: 1997-10-17
Granted: 2005-04-07
Abstract: A hemostasis valve including a collapsible membrane in a portion of a through-lumen. Fluid pressure in a chamber surrounding the collapsible membrane assists in sealing the collapsible membrane around an operating device inserted through the hemostasis valve. Different mechanisms for mechanically deforming the collapsible membrane to assist in sealing are disclosed. Also, a system for continuously flushing a vascular catheter connected to a hemostasis valve at a rate of 0.10 to 10.0 cubic centimeters per minute, and a hemostasis valve assembly including an expandable reservoir which stores liquid volume under pressure.
Patent DE-69737413-T2 (DE)
Inventor: BYRNE WILLIAM
IPC: A61K39/106
Filed: 1997-01-03
Granted: 2007-10-31
Abstract: A nucleic acid sequence encoding all or part of an 18-19 kDa Helicobater pylori protein is described to which immunoreactivity is detected in H. pylori negative individuals. A process for the production of a recombinant form of this protein and its use, particularly as a vaccine to provide immunological protection against H. pylori infection are also described.
Patent DE-69815828-T2 (DE)
Inventor: CREMASCHI DARIO
IPC: A61K9/18
Filed: 1998-04-08
Granted: 2004-05-19
Abstract: Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration.
Patent DE-69821063-T2 (DE)
Inventor: DUDLEY STEVEN JOHN
IPC: F16L37/02
Filed: 1998-08-14
Granted: 2004-12-23
Abstract: A tube coupling comprises a plastic body defining a socket portion 2 for receiving a tube, a seal 24 within the socket portion, means 28, 32 for gripping the tube, and a metal reinforcing sleeve 8 on the outside of the body extending over at least part of the socket portion, wherein the part of the socket portion covered by the sleeve 8 is provided with an annular outwardly projecting locating ridge 14 and the sleeve 8 is provided with a corresponding annular outwardly projecting locating portion whose inner side defines a recess which receives the ridge 14. <IMAGE>
Patent DE-69826842-T2 (DE)
Inventor: CRANE THOMAS
IPC: A61K39/39
Filed: 1998-04-01
Granted: 2005-11-24
Abstract: An aqueous adjuvant composition comprising an attenuated lipid A derivative and a surfactant or surfactants enhances the immunological response in a warm blooded animal to a protein antigen. Attenuated lipid A derivatives useful according to the subject invention include monophosphoryl lipid A and 3-O-deacylated monophosphoryl lipid A. A surfactant or mixtures of surfactants are dissolved in a solvant. 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine is a preferred surfactant. The dissolved surfactant is added to an attenuated lipid A derivative to obtain a mixture. The molar ratio of attenuated lipid A derivative to surfactant in the mixture is about 4:1. The solvent is evaporated and water is added to the resulting film. The suspension is sonicated in a 60  DEG C water bath until it becomes clear. Animals administered the adjuvant formulation exhibited increased antibody responses to a given antigen as well as displayed enhanced lymphocyte proliferative and cytotoxic T-lymphocyte responses. Intranasal administration of the aqueous adjuvant composition and an antigen stimulates the production of serum and mucosal secreted IgA.
Patent DE-69837718-T2 (DE)
Inventor: FOSNIGHT WILLIAM J
IPC: B65G1/04
Filed: 1998-03-26
Granted: 2007-09-06
Abstract: An integrated intrabay buffer, delivery, and stocker system including a pair of shuttles, capable, by themselves, of transferring a pod in an X-Z plane between the interbay transport system, the I/O ports of various process tools and a plurality of storage shelves provided along the wall of the tool bay. Advantageously, the present invention integrates together the process tools within a tool bay by providing a single transport mechanism shared by each tool, and by providing a single, large storage and buffer area for pods that is shared by each tool. This increases reliability and flexibility, and simplifies the hardware and software control. Additionally, the storage shelves may be provided above some or all of the process tools within the tool bay. Such an arrangement offers a substantially greater number of spaces to store a pod as compared to conventional tool bays. Moreover, as the space above processing tools is currently unused, in part because a clear, unobstructed path above the I/O ports of the processing tools must be available in conventional systems, the increased storage capacity according to the present invention may be provided without increasing the footprint of conventional tool bays.
Patent DE-69900462-T2 (DE)
Inventor: COULL JAMES
IPC: C07H21/00
Filed: 1999-02-10
Granted: 2002-07-11
Abstract: Disclosed herein are methods for linking a protein or other biomolecule containing a carboxylic acid moiety to a PNA or DNA probe molecule. The methods disclosed herein involve activating the carboxylic acid moiety with an activating agent and reacting the activated carboxylic acid moiety with a PNA or DNA probe having an arylamine or aminooxyacetyl moiety. Conjugates produced by these methods are also disclosed.
Patent DE-69903923-T2 (DE)
Inventor: BARKER JOHN
IPC: A61P43/00
Filed: 1999-02-02
Granted: 2003-07-10
Abstract: A pharmaceutical composition comprising a compound of formula (I):or a pharmaceutically acceptable salt, ester or amide thereof, which is an inhibitor of monocyte chemoattractant protein-1 and wherein A and B together form an optionally substituted 5-member aromatic ring which includes at least one heteroatom; R1 is an optionally substituted aryl or heteroaryl ring; R2 is selected from a range of organic groups including carboxy, and R3 is hydrogen, or a range of organic groups; in combination with a pharmaceutically acceptable carrier. Certain compounds of formula (I) are novel and these form a further aspect of the invention.
Patent DE-69908604-T2 (DE)
Inventor: RICCI PATRIZIO
IPC: C11D1/62
Filed: 1999-07-07
Granted: 2004-04-29
Abstract: A multi-phase detergent tablet comprising:   a) a first phase in the form of a shaped body having at least one mould therein; and b) a second phase in the form of a compressed body adhesively contained within said mould, wherein the tablet composition comprises one or more detergent actives which is predominantly concentrated in the second phase, and wherein the second phase additionally comprises a disrupting agent. The multi-phase tablets provide improved dissolution and cleaning characteristics together with excellent tablet integrity and strength.
Patent DE-69914493-T2 (DE)
Inventor: SEIDEL MICHAEL
IPC: C07B61/00
Filed: 1999-09-02
Granted: 2004-07-22
Abstract: A process for the preparation of 2-hydroxy-6-trifluoromethylpyridine which comprises reacting 2-fluoro-6-trifluomethylpyridine or a mixture of 2-fluoro-6-trifluoromethylpyridine and 2-chloro-6-trifluoromethylpyridine with an alkali metal hydroxide at a temperature of from 50 DEG  C. to 160 DEG  C. and acidifying the product so formed.
Patent DE-69916266-T2 (DE)
Inventor: RE G
IPC: A61K31/5575
Filed: 1999-06-08
Granted: 2005-03-10
Abstract: This invention comprises new formulations and methods of preparing a new formulations of prostaglandins and in particular dinoprost tromethamine, where the pH of the formulation is adjusted to between about 5.5-7.5 and where the the concentration of benzyl alcohol is between about 1.2 to 2.0 mg/ml.
Patent DE-69922915-T2 (DE)
Inventor: MOILANEN STEVEN M
IPC: B25B5/16
Filed: 1999-10-20
Granted: 2006-04-06
Abstract: Adjustable stoppers for limiting the angle at which pivotal gripper jaws (200) are opened. The stoppers include a stop block (205) and at least one stopper pad (207) which is made from a shock absorbing material such as urethane. The stoppers are secured to a pivotal one of a pair of gripper jaw members of a parts gripper and positioned to abut the other of the pair of gripper jaw members. Stoppers which are provided with two or more stopper pads of different lengths are reversible and can be used to adjust the angle at which the jaw members open. <IMAGE>
Patent DE-69923854-T2 (DE)
Inventor: KLEIN S
IPC: A61K31/382
Filed: 1999-09-24
Granted: 2006-01-12
Abstract: Methods and compositions for inhibiting or preventing spermatogenesis in a male mammal. Also disclosed are compounds and formulations for use in such methods.
Patent DE-69935341-T2 (DE)
Inventor: BAILLS STEPHANE LAURENT
IPC: H04L7/04
Filed: 1999-12-07
Granted: 2007-12-06
Abstract: The invention relates to a radio communication system in which a time slot of a frame of a multiframe signal allocated to the frequency control channel is modulated using an 8PSK modulation scheme to contain a tone having a frequency which GMSK modulation is unsuited to generate. This enables COMPACT-format signals to be distinguished from GSM - format signals and ensures backwards compatibility with all existing GSM mobile stations. <IMAGE>
Patent DE-69936825-T2 (DE)
Inventor: KAPUR VIJAY K
IPC: H01L21/365
Filed: 1999-06-30
Granted: 2008-05-15
Abstract: A method for forming a compound film includes the steps of preparing a source material, depositing the source material on a base and forming a preparatory film from the source material, heating the preparatory film in a suitable atmosphere to form a precursor film, and providing suitable material to said precursor film to form the compound film. The source material includes oxide-containing particles including Group IB and IIIA elements. The precursor film includes non-oxide Group IB and IIIA elements. The compound film includes a Group IB-IIIA-VIA compound. The oxides may constitute greater than about 95 molar percent of the Group IB elements and greater than about 95 molar percent of the Group IIIA elements in the source material. Similarly, non-oxides may constitute greater than about 95 molar percent of the Group IB elements and greater than about 95 molar percent of the Group IIIA elements in the precursor film. The molar ratio of Group IB to Group IIIA elements in the source material may be greater than about 0.6 and less than about 1.0, or substantially greater that 1.0, in which case this ratio in the compound film may be reduced to greater than about 0.6 and less than about 1.0. The source material may be prepared as an ink from particles in powder form. The oxide-containing particles may include a dopant, as may the compound film. Compound films including a Group IIB-IVA-VA compound may be substituted using appropriate substitutions in the method. The method, also, is applicable to fabrication of solar cells and other electronic devices.
Patent DE-69937209-T2 (DE)
Inventor: MATSUMOTO HITOSHI
IPC: B41J2/175
Filed: 1999-05-25
Granted: 2008-07-03
Abstract: An ink jet printing apparatus comprising: a print head for ejecting ink droplets; an ink cartridge (10',20') containing ink therein for supplying the ink to said print head; a memory device (32) for storing data related to the ink cartridge; and a control device (60) accessible to said memory device (32) for controlling said print head whereby the control device uses data stored in the memory device to manage recycling of the ink cartridge.
Patent DE-69937361-T2 (DE)
Inventor: HAKIM NOURI E
IPC: A61J11/00
Filed: 1999-08-20
Granted: 2008-07-17
Abstract: Improved pacifier baglets and baby bottle nipples having protrusions thereon to rub against the child's gums and thereby assist with teething. The protrusions can be of any desired shape or configuration. In a further embodiment, the baglets and nipples include materials of at least two hardnesses, with a harder material being provided in the protrusions to further facilitate the teething process.
Patent HU-E032404-T2 (HU)
Title: Inhibitors of hepatitis c virus
Inventor: BJORNSON KYLA
IPC: C07K5/08
Filed: 2013-07-02
Abstract: Compounds of Formula (IV), as well as pharmaceutically acceptable salts thereof, are disclosed:
   
The compounds are useful in the treatment of Hepatitis C infections.
Patent TR-200001668-T2 (TR)
Title: Dengeli pH profiline sahip yapı
Inventor: WALLAJAPRT PLANI RAJ RAMASWAMI
IPC: A61F13/00
Filed: 1998-12-09
Abstract: Bu tarifnamede asit veya baz yapida, suyla sisen, suda çözünmeyen bir polimer, baz veya asit ikinci madde, opsiyonel olarak bir tampon madde içeren ve istenilen absorpsiyon özelliklerini sergileyen bir emici madde tarif edilmektedir. Spesifik olarak, bu bulus bir yanda büyük miktarlarda su absorbe etme kapasitesine sahip olan ve öte yanda üst yüzeyindeki pH profilini dengede tutabilen bir emici yapi ile ilgilidr. Bu emici yapi vücut sivilarini absorbe etmek için kullanilan tek kullanimlik ürünler gibi sivi emici tek kullanimlik ürünlerde yarar saglamaktadir.
Patent TR-200001681-T2 (TR)
Title: Palladyum, altın, bakır kapsayan vinil asetat katalizörü.
Inventor: MICOLAU IOAN
IPC: C07C67/055
Filed: 1998-12-03
Abstract: Metalik palladyum ve altinin katalitik olarak etkin miktarlarinin, serbest metal olarak bakirin ya da bakir asetatin ve magnezyum, kalsiyum, baryum ve zirkonyumdan meydana gelen gruptan seçilen bir dördüncü metalin oksidi ya da oksit ve serbest metalin bir oksidi halinde biriktigi gözenekli yüzeyler üzerinde, gözenekli bir destegi kapsayan reaktanlar olarak, etilen, oksijen asetik asetik asidin reaksiyonu ile vinil asetatin üretilmesi için bir katalizör.
Patent TR-200001842-T2 (TR)
Inventor: GISSMANN LUTZ
IPC: A61P31/12
Filed: 1998-10-06
Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
Patent TR-200001927-T2 (TR)
Inventor: CONNELL RICHARD D
IPC: C07D311/66
Filed: 1998-12-16
Abstract: This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
Patent TR-200002424-T2 (TR)
Title: Bisiklet selesi
Inventor: BAVARESCO ROBERTO JOSE
IPC: B62J1/00
Filed: 1999-02-18
Abstract: Bulus, bisiklet çerçevesine tespit edilen bir destek ünitesi (4) tarafindan tasinan iki ayri oturma elemani (2,3) içeren bir bisiklet selesiyle (1) ilgilidir. Her bir oturma elemani (2,3), bahsi geçen destek ünitesine (4) göre sabit olan en az bir ilk parça (2',3') ve ilk parçaya göre hareketli olan en az bir ikinci parçayi (2",3") içerir. Bahsi geçen ikinci parça (2",3") bisikletin hareket yönüne (6) dik olarak yerlestirilen yatay bir ekseni (10a,11a) belirleyen bir disli miline (10,11) döner sekilde baglanmistir.
Patent TR-200002472-T2 (TR)
Inventor: BOHIN FABRICE
IPC: C08K5/05
Filed: 1999-02-24
Abstract: The invention concerns a cross-linkable adhesive silicone composition, and the use of said composition for bonding various substrates, comprising: a polyorganosiloxane (POS) with Si-Vi(polydimethylsiloxane alpha,omega-dj-Vi) units; a crosslinking POS with SiH units; a platinum catalyst; an adherence promoter comprising vinyltrimethoxysilane, 3-glycidoxy-propyltrimethoxysilane and buryl titanate; and optionally a filler and/or a cross linkage inhibitor and/or an unsaturated POS resin such as MMviDDviQ or MDviQ. The invention aims at providing a highly adhesive glue having, before setting, a low viscosity adapted for easy application on the substrates to be bonded. The invention achieves this by providing a cross-linkable adhesive silicone composition as defined above and characterised in that it has a peeling force Fp>=0.25 N/mm. a viscosity eta>=50.103mPa's at 25°, a tear resistance Rd>=6/mm (ASTM-624A) and a Shore hardness A>=35. The invention also concerns the use of said composition as adhesive.
Patent TR-200102164-T2 (TR)
Title: Delikli malzeme tabakası.
Inventor: PICCINI ANDREA
IPC: A47K7/02
Filed: 2000-01-20
Abstract: Bu bulus malzeme tabakalarina, tercihen ev ve endüstri tipi yüzeylerin silinmesinde kullanim için islak silme bezlerine ilave olarak bu tabakalarin, bebek silme bezleri, makyaj çikarma ve diger cilt bakim uygulamalari gibi insan vücudu üzerindeki kullanimlarina iliskindir. Islak silme bezleri, delinme konumunun görünürlügü ve silme bezlerinin çikarilma ve ayrilma kolayliginin gelistirilmesi için gelistirilmis bir delinme konfigürasyonu ile donatilmistir. Böylece, kullanim esnasinda yirtilmanin engellenmesi için yeterli mukavemet temin edilmistir.